PATENT CLAIM ANALYSIS

Application Number: 15744502
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "291000"]

Abstract:
The present invention relates to the field of tissue injury. More specifically, the present invention provides pharmaceutical compositions useful for the treatment of tissue injury. In certain embodiments, a pharmaceutical composition comprises (a) a stem cell mobilizer and (b) an immunosuppressive agent or non-immunosuppressive FK binding protein ligand. The pharmaceutical compositions of the invention can be administered by a variety of routes and dosing regimens.

Claim (Index 27):
A method of treating a tissue injury in a subject, comprising the steps of administering the pharmaceutical composition of  claim 1  to the subject in one or more doses on the day the tissue injury was incurred or observed, in one or more doses at about one month after the day the tissue injury was incurred or observed, in one or more doses at about two months after the day the tissue injury was incurred or observed and in one or more doses at about three months after the tissue injury the day the tissue injury was incurred or observed.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14814988', '14006053', '12747302', '14126768', '13518513']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7605782753558419
- 35 USC 102 Novelty (BERT): 0.543326928401182
- Combined Prediction Score: 0.7388531406603759
- Mean Citation Score: 290.261294
- Max Citation Score: 420.67328
- Similarity Product: 242.08463952453613

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test